Morgan Stanley analyst Ricky Goldwasser initiates coverage on LifeStance Health Group (NASDAQ:LFST) with a Overweight rating and announces Price Target of $36.
One of the most devastating long-term impacts of the COVID-19 pandemic may be the toll it has taken on people’s mental health. The next global health crisis may be related to mental health issues such as anxiety and depression, and companies that are focused on mental health could be well-positioned to capitalize on the opportunity.
@SenateCA Banking committee report to be tabled in chamber today. Third Reading debate starting Thursday. No amendments @ committee but Observations attached. This doesn’t change the Bill (like an amendment
After a shortened holiday week that saw only one large public listing, the week of June 7 heats up with numerous listings across several different sectors. These include several companies that work with some of the leading technology companies and a couple of Chinese companies going public in the U.S.
Here is a look at the top offerings of the week.